Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
Detailed Information | |
---|---|
Biomarker ID | 669 |
PMID | 21647377 |
Year | 2011 |
Biomarker | miR-143 |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in Bone Metastatis: 12.9 fold |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:- DNA-binding transcription factor activity; Senescence and Autophagy in Cancer; Glioma; Focal adhesion; Melanoma |
Experiment | Primary vs Bone Metastatis |
Type of Biomarker | Prognostic |
Cohort | Samples of 16 primary PCa and 13 bone metastases were selected for analysis |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.012 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | miR-143 |